NHGRI source snapshot
2021 State Bills Oklahoma 2021 SB 351
Oklahoma
Retrieved from NHGRI
NHGRI summary
Requires a practitioner to offer to administer a pharmacogenomic test to a patient prior to the prescription of any psychotropic drug. The practitioner is required by the measure to inform the patient that pharmacogenomic tests have not been approved by the Food and Drug Administration. The practitioner must obtain the patient�s informed consent prior to ordering a pharmacogenomic test and must provide an estimate to the patient if the practitioner is aware of the cost. 2/2/2021 Second Reading. Referred to Senate Health and Human Services. Carries over to 2022.
Source links
- Open the primary link recorded by NHGRI
- View the NHGRI Genome Statute and Legislation Database
- Browse other Oklahoma source records
Legacy link: NHGRI recorded this destination using unencrypted HTTP. The link may be stale or unavailable.
Provenance
Courtesy: National Human Genome Research Institute. This source layer preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.